骨质疏松骨折风险评估

被引:10
作者
陈懿 [1 ]
尹知训 [2 ]
李之琛 [2 ]
余楠生 [2 ]
机构
[1] 北京诺华制药有限公司医学部
[2] 广州医学院第一附属医院骨科
关键词
骨质疏松骨折; 患者; BMD; FRAX; 骨密度值; 骨折风险; 风险评估;
D O I
暂无
中图分类号
R580 [];
学科分类号
1002 ; 100201 ;
摘要
<正>骨质疏松症是最为常见的一种代谢性骨病,骨质疏松骨折,又被称为脆性骨折,常发生于低于站立体位跌倒之后。骨质疏松骨折直接导致患者急慢性疼痛,活动受限,精神受挫,与髋部骨折相关联的患者的死亡率增加了大约20%[1]。因此,以减少骨折发生风险为目的的骨质疏松治疗至关重要,但是,由于骨量丢失通常在无症状的情况下发生,甚至2/3的脊柱骨折不伴有临床症状,在诊疗中通常被忽视
引用
收藏
页码:643 / 647
页数:5
相关论文
共 18 条
[2]  
Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)[J] . Elaine M. Dennison,Juliet E. Compston,Julie Flahive,Ethel S. Siris,Stephen H. Gehlbach,Jonathan D. Adachi,Steven Boonen,Roland Chapurlat,Adolfo Díez-Pérez,Frederick A. Anderson,Frederick H. Hooven,Andrea Z. LaCroix,Robert Lindsay,J. Coen Netelenbos,Johannes Pfeilschifter,Maurizio Rossini,Christian Roux,Kenneth G. Saag,Philip Sambrook,Stuart Silverman,Nelson B. Watts,Susan L
[3]  
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary[J] . Papaioannou,Alexandra,Morin,Suzanne,Cheung,Angela M,Atkinson,Stephanie,Brown,Jacques P,Feldman,Sidney,Hanley,David A,Hodsman,Anthony,Jamal,Sophie A,Kaiser,Stephanie M,Kvern,Brent,Siminoski,Kerry,Leslie,William D.Canadian Medical Association. Journal . 2010 (17)
[4]  
Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.—Conformity between methods and their clinical utility[J] . W. Pluskiewicz,P. Adamczyk,E. Franek,P. Leszczynski,E. Sewerynek,H. Wichrowska,L. Napiorkowska,T. Kostyk,M. Stuss,W. Stepien-Klos,K.S. Golba,B. Drozdzowska.Bone . 2010 (6)
[5]   Impact of a primary care physician workshop on osteoporosis medical practices [J].
Laliberte, M. -C. ;
Perreault, S. ;
Dragomir, A. ;
Goudreau, J. ;
Rodrigues, I. ;
Blais, L. ;
Damestoy, N. ;
Corbeil, D. ;
Lalonde, L. .
OSTEOPOROSIS INTERNATIONAL, 2010, 21 (09) :1471-1485
[6]  
Prognosis of fracture: evaluation of predictive accuracy of the FRAX? algorithm and Garvan nomogram[J] . S. K. Sandhu,N. D. Nguyen,J. R. Center,N. A. Pocock,J. A. Eisman,T. V. Nguyen.Osteoporosis International . 2010 (5)
[7]  
Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX ?[J] . John A. Kanis,Helena Johansson,Anders Oden,Eugene V. McCloskey.Bone . 2009 (6)
[8]  
FRAX ? and its applications to clinical practice[J] . Bone . 2009 (5)
[9]  
Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomised study[J] . E. V. McCloskey,H. Johansson,A. Oden,S. Vasireddy,K. Kayan,K. Pande,T. Jalava,J. A. Kanis.Osteoporosis International . 2009 (5)
[10]  
Case finding for the management of osteoporosis with FRAX ? —assessment and intervention thresholds for the UK[J] . J. A. Kanis,E. V. McCloskey,H. Johansson,O. Strom,F. Borgstrom,A. Oden.Osteoporosis International . 2008 (10)